Register Here

2018 Associate Sponsors

ICON

2018 Media Partners

CanBiotech

Overview

The Clinical Trial Collaborations (CTC) conference focused on arguably the most important change in drug development: How we are altering the way we collaborate to drive greater efficiencies in productivity and bring us closer to the patient.

At the 2nd annual CTC event, we presented a wide variety of sessions, which demonstrated new ways of collaborating for improved clinical trial outcomes as well as addressing how to strike a better balance in the delivery model for effective drug development.

We were pleased to announce that the 2017 conference opened with Ken Getz, Director of Sponsored Research Programs, Tufts CSDD, on how the Clinical Collaborations Landscape is Changing and its Impact on R&D Operations.

kenandkatherine-2

Ken Getz, Tufts CSDD, Opening Speaker and Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, Inc

Immediately following this session was a fireside keynote discussion with Dr Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck, who joined Ken in an honest and open discussion on Models for Exquisite Project Delivery with Internal and External Partners.

Another keynote was Dr Andy PlumpChief Medical & Scientific Officer, Takeda  and Dr Steve Cutler, CEO, ICON. We were delighted to welcome back Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, Inc, as Chair. New to the program Katherine Capparella and Bennett Levitan, provided a case study on how Janssen is creating strategic collaborations that are driving patient centered trials.

2017 Keynotes

Andrew_Plump_153px

Dr Andy Plump, Chief Medical & Scientific Officer, Takeda

andylee

Dr Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck

steve-cutler-1b

Dr Steve Cutler, CEO, ICON

Clinical Research as a Care Option

We were particularly excited to present a collaborative session on Clinical Research as a Care Option. This section of the 2018 CTC event made up 25% of the program and for good reason. If we really want to bring patients closer to clinical research, we have to figure out how to collaborate to make clinical trials a care option. Higher rates of clinical trial participation inside a health system produces better patient outcomes, lower cost of care and happier patients. Health systems and patients get access to the latest research and pharma gets access to more patients. This is why we dedicated the entire day of April 11 to working through the process of how to make this a reality.

New to the 2017 Conference: Partnering Tool

adrianmurraymitch-2

Adrian Otte, Amgen, Dr Murray Abramson, Biogen and Dr Mitch Katz, Purdue will be joining CTC 2017

Also new to the 2017 event was access to a partnering tool and partnering facilities to have small group and one-on-one meetings.

CTC presented insightful ideas and challenges for R&D operations, CROs and site executives to discover new ways of collaborating. The conference is designed for senior level clinical operation executives from large, medium and small pharmas, CROs and sites. Patient advocacy organizations are also encouraged to attend.


Sincerely,

Valerie Bowling New

 

Valerie Bowling
Executive Director

 

Meredith Sands
Executive Director, Business Development

 Elizabeth Bard B&W

Elizabeth Bard
Business Development Manager

 

Jackie Della Torre
Business Development Manager

 

Bridget Halstead
Senior Conference Planner

 

Allyson Adams
Conference Producer


Testimonials

  • "Topics were well defined and the presenters focused in on topics without meandering into other areas of discussion."

    - Joshua Fama, ISDM Solutions LLC

  • "I enjoyed the keynote speakers and the group panels."

    - Jamie Kime, UCB